Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News

‘Super Movers’ May Have Slower Cognitive Decline

Fast-walking ‘super movers’ aged 80 years or older have about half the risk for cognitive impairment but no less Alzheimer’s disease pathology.

Sanofi to Stop Disparaging Rival Flu Vaccine to Stave Off EU Antitrust Fine

French pharmaceutical company Sanofi has offered to state publicly that ⁠a rival flu vaccine is as effective as its own, EU antitrust regulators said on Wednesday of the...

India's Dr Reddy's Says Semaglutide Shipping Disruption to Last Until At Least Late October

India's Dr Reddy's Laboratories said on Thursday that supplies of its generic semaglutide would remain unavailable in India and face disruptions in Canada until at least...

RSV Preventive Strategies Tied to Fewer Bronchiolitis Cases

Administration of nirsevimab and RSV vaccination in pregnant women are tied to significant reductions in hospitalized days and oxygen requirements among infants with bronchiolitis.

Light Activity Pays Off for COPD Survival

New data show that patients need not exercise intensely to improve outcomes.

Initial Prescription Duration May Shape Benzodiazepine Use

Longer durations of initial prescriptions are associated with prolonged use of benzodiazepines compared with durations of 7 days or less, a large cohort study shows.

Todays Updates

PPI, Antibiotics May Curb Durvalumab Efficacy in NSCLC

Study adds to evidence that the widely used medications may interfere with immunotherapy efficacy via effects on the gut microbiome.

FDA Approves Subcutaneous Isatuximab for MM Indications

The drug can now be administered with the hands-free automated CirCLIQ on-body injector.

Todays Updates

PPI, Antibiotics May Curb Durvalumab Efficacy in NSCLC

Study adds to evidence that the widely used medications may interfere with immunotherapy efficacy via effects on the gut microbiome.

FDA Approves Subcutaneous Isatuximab for MM Indications

The drug can now be administered with the hands-free automated CirCLIQ on-body injector.

Latest News

Fast-walking ‘super movers’ aged 80 years or older have about half the risk for cognitive impairment but no less Alzheimer’s disease pathology.

French pharmaceutical company Sanofi has offered to state publicly that ⁠a rival flu vaccine is as effective as its own, EU antitrust regulators said on Wednesday of the...

India's Dr Reddy's Laboratories said on Thursday that supplies of its generic semaglutide would remain unavailable in India and face disruptions in Canada until at least...

Administration of nirsevimab and RSV vaccination in pregnant women are tied to significant reductions in hospitalized days and oxygen requirements among infants with bronchiolitis.

New data show that patients need not exercise intensely to improve outcomes.

Longer durations of initial prescriptions are associated with prolonged use of benzodiazepines compared with durations of 7 days or less, a large cohort study shows.

News All Time

New Artificial Neurons Cause Living Brain Cells to Fire

An array of artificial neurons printed on a flexible wafer produce spiking waveforms closely matching biological action — and drive living mouse brain cells to fire.

China Outpacing Europe in Drug Innovation, Pfizer Executive

China has pulled ahead of Europe in pharmaceutical innovation and drug development, a senior Pfizer executive ⁠said on Tuesday.

PCR Testing Finds Infections in Lung Transplant Recipients

Tests show greatest value when used alongside imaging.

European Patient Access to New Drugs Worsens

Patient access to new medicines is worsening across Europe, the region's main pharmaceuticals industry ⁠lobby group said.

Wrist Air Samplers Detect Virus Exposure in Kids With Asthma

Devices may inform disease prevention strategies by providing community-level data.

Colistin MIC Affects Outcomes in Gram-Negative Infections

In carbapenem-resistant gram-negative infections caused by pathogens for which the colistin MIC is 2 mg/L, the colistin-meropenem combination is linked to better clinical outcomes than colistin alone.

What 300,000 Implants Say About Light Adjustable Lens

An intraocular lens that can be adjusted after cataract surgery has better outcomes for meeting target vision than other lenses, but patient selection and involvement are key.

Parkinson’s Disease Deaths Decline Among Older US Adults

Death rates from Parkinson’s disease among US older adults decline in 2024 following a steady rise from 2014 to 2021, new data show.

Sri Lanka Battles Surge in Dengue Fever, With More Than 44,000 Cases So Far This Year

Sri Lanka is battling the worst outbreak of mosquito-borne dengue fever in years, with more than ⁠44,000 cases and 28 deaths recorded since January, an official said on...

More Than 70 Congo Medics Infected With Ebola Since Outbreak Started, WHO Says

A senior World Health Organization official said on Friday that 75 ⁠medics in the Democratic Republic of Congo had been infected with Ebola and 17 of ⁠them had died since...

US Progesterone Supplies Tighten as Menopause Treatment Demand Grows

U.S. supplies of progesterone are coming under strain, with patients, clinicians, and pharmacists reporting recent intermittent shortages of oral versions of the hormone...

Moderna's MRNA Flu Vaccine Backed by FDA Advisers

Advisers to the U.S. Food and Drug Administration on Thursday backed approval of Moderna's flu vaccine for adults aged 50 and older, saying its benefits outweigh its risks,...

Mycobacteria May Predict Graft Failure After Lung Transplant

Early isolation can be a biomarker for patients at increased risk for poor outcomes.

Safety Gaps Put Patients at Risk Across NHS Pathways

NHS patients may face delays in accessing specialist care because of accountability failures and data-sharing gaps across regional pathways, HSSIB has warned.

Moderna Flu Shot Data May Support Use in Older Adults, US FDA Staff Says

U.S. Food and Drug Administration staff reviewers said on Tuesday data demonstrating an immune response to Moderna's flu shot may support effectiveness in adults ⁠65 years...

Ebola Risk for World Cup Is 'Extremely Low', but US Is Ready, Experts Say

The risk that a traveler infected with Ebola could arrive in the United States during the 2026 World Cup tournament that kicked off last week is low but not zero, and if...

Recommended News For You

A novel test shows promise for finding cervical adenocarcinoma, which is difficult to find.

Severe obesity associated with reduced prevalence of recommended cancer screenings

mRNA-based COVID vaccines generate improved responses to immunotherapy

Potential targets for treating the most common type of liver cancer in children have been identified by a collaborative study.

A small rise in cancer was observed following the 1986 Chernobyl accident.

Detecting invasive nodules could be key to preventing unnecessary pancreatic cancer surgery

CAR Natural Killer Cell Therapy Shows Promise in B-Cell Lymphomas

Recommended Articles For You

Deciphering FFR: A Comprehensive Guide to Understanding Its Meaning  

Revolutionizing Cancer Treatment: ESMO's Updated Recommendations for Tumour NGS 

The Importance of Maintaining Normal Calcium Levels in Your Body  

Hypogammaglobulinemia: A Comprehensive Guide for Patients and Caregivers 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Never in a million years did I think I'd have to limit my chemotherapy.

2.

PET-CT is better than contrast-enhanced CT as a predictor of survival in patients with metastatic breast cancer

3.

A small rise in cancer was observed following the 1986 Chernobyl accident.

4.

Taking Charge of Your Cancer Journey.

5.

FDA OKs Subcutaneous Daratumumab Plus VRd for Myeloma

1.

Imaging in Peritoneal Neoplasms: Diagnostic Advances and Multimodal Treatment Strategies

2.

What You Need To Know About Trametinib: A Miracle Cancer Treatment?

3.

Blastic Plasmacytoid Dendritic Cell Neoplasm and the Dawn of AI-powered Diagnostics

4.

Breaking Barriers in Cancer Treatment: The Role of Innovative Oncology Drugs

5.

Understanding Sepsis and Precision-Medicine-Based Immunotherapy: A Pathophysiological Perspective

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV

2.

CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World

3.

Dacomitinib Case Presentation: Baseline Treatment and Current Status

4.

Newer Immunotherapies for Myeloma- A Comprehensive Overview

5.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot